Thomas Quinn

Finance Director at Akero Therapeutics - South San Francisco, CA, US

Thomas Quinn's Colleagues at Akero Therapeutics
Timothy Rolph

Chief Scientific Officer

Contact Timothy Rolph

John CEP

Vice President Finance and Controller

Contact John CEP

Kitty Yale

EVP and Chief Development Officer

Contact Kitty Yale

Brittany De Temple

director of clinical operations and program management

Contact Brittany De Temple

Yuan Xu

Independent Board Director

Contact Yuan Xu

View All Thomas Quinn's Colleagues
Thomas Quinn's Contact Details
HQ
650-487-6488
Location
Boston, Massachusetts
Company
Akero Therapeutics
Thomas Quinn's Company Details
Akero Therapeutics logo, Akero Therapeutics contact details

Akero Therapeutics

South San Francisco, CA, US • 20 - 49 Employees
BioTech/Drugs

Akero Therapeutics is a clinical-stage cardio-metabolic company developing transformational treatments for non-alcoholic steatohepatitis (NASH), a disease without any approved therapies. Akero's lead product candidate, efruxifermin (EFX), an engineered Fc-FGF21 fusion protein, is currently being evaluated in a Phase 2b clinical trial as a potential treatment for NASH. Akero is headquartered in South San Francisco.

N/A
Details about Akero Therapeutics
Frequently Asked Questions about Thomas Quinn
Thomas Quinn currently works for Akero Therapeutics.
Thomas Quinn's role at Akero Therapeutics is Finance Director.
Thomas Quinn's email address is ***@akerotx.com. To view Thomas Quinn's full email address, please signup to ConnectPlex.
Thomas Quinn works in the BioTech/Drugs industry.
Thomas Quinn's colleagues at Akero Therapeutics are Timothy Rolph, Louben Dorval, John CEP, Yasmine CPA, Kitty Yale, Brittany De Temple, Yuan Xu and others.
Thomas Quinn's phone number is 650-487-6488
See more information about Thomas Quinn